Christine Mackenzie 5/27/25 Christine Mackenzie 5/27/25 Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics Read More Jamison Wright 2/19/25 Jamison Wright 2/19/25 Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience Read More Jamison Wright 1/24/25 Jamison Wright 1/24/25 Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor Donello (2025) Read More Jamison Wright 12/12/24 Jamison Wright 12/12/24 Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting Read More Jamison Wright 12/3/24 Jamison Wright 12/3/24 Gate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression Read More Jamison Wright 5/15/24 Jamison Wright 5/15/24 Gate Neurosciences to share new data and research on its synaptic function molecules with multiple posters at 2024 ASCP meeting Read More Jamison Wright 1/4/24 Jamison Wright 1/4/24 Targeting metaplasticity mechanisms to promote sustained antidepressant actions Gould (2024) Read More Jamison Wright 3/3/23 Jamison Wright 3/3/23 Aprison Lecture - Novel Approach to NMDA Modulation, Plasticity, Rapid Antidepressant Drugs Shekhar (2023) Read More Jamison Wright 1/3/23 Jamison Wright 1/3/23 NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine Zanos (2023) Read More Jamison Wright 12/12/22 Jamison Wright 12/12/22 Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects Donello (2022) Read More Jamison Wright 10/15/20 Jamison Wright 10/15/20 Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons Duman (2020) Read More
Christine Mackenzie 5/27/25 Christine Mackenzie 5/27/25 Syndeio Biosciences Launches to Lead the Emerging Field of Synapse-Targeted Neurotherapeutics Read More
Jamison Wright 2/19/25 Jamison Wright 2/19/25 Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience Read More
Jamison Wright 1/24/25 Jamison Wright 1/24/25 Demystifying the Antidepressant Mechanism of Action of Stinels, a Novel Class of Neuroplastogens: Positive Allosteric Modulators of the NMDA Receptor Donello (2025) Read More
Jamison Wright 12/12/24 Jamison Wright 12/12/24 Gate Neurosciences Presents New Data and Insights Highlighting Unique Pharmacology of Synaptic Function Modulators at the 2024 ACNP Annual Meeting Read More
Jamison Wright 12/3/24 Jamison Wright 12/3/24 Gate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression Read More
Jamison Wright 5/15/24 Jamison Wright 5/15/24 Gate Neurosciences to share new data and research on its synaptic function molecules with multiple posters at 2024 ASCP meeting Read More
Jamison Wright 1/4/24 Jamison Wright 1/4/24 Targeting metaplasticity mechanisms to promote sustained antidepressant actions Gould (2024) Read More
Jamison Wright 3/3/23 Jamison Wright 3/3/23 Aprison Lecture - Novel Approach to NMDA Modulation, Plasticity, Rapid Antidepressant Drugs Shekhar (2023) Read More
Jamison Wright 1/3/23 Jamison Wright 1/3/23 NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine Zanos (2023) Read More
Jamison Wright 12/12/22 Jamison Wright 12/12/22 Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects Donello (2022) Read More
Jamison Wright 10/15/20 Jamison Wright 10/15/20 Positive modulation of NMDA receptors by AGN-241751 exerts rapid antidepressant-like effects via excitatory neurons Duman (2020) Read More
